Judith Fradkin, MD

Director of the Division of Diabetes, Endocrinology, and Metabolic Diseases at the National Institutes of Health

Dr. Judith E. Fradkin became the Director of the Division of Diabetes, Endocrinology, and Metabolic Diseases (DEMD) at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) in 2000. She had previously served as the Deputy Director of the Division, Chief of the Endocrinology and Metabolic Diseases Programs Branch, Acting Chief of the Diabetes Research Programs Branch, and Director of the Cystic Fibrosis Research Program within the Division. 

Dr. Fradkin graduated magna cum laude from Harvard College, received her medical degree from the University of California at San Francisco, and completed her internship and residency in internal medicine at Harvard’s Beth Israel Hospital in Boston. She came to NIDDK as a clinical associate in 1979 after an endocrinology fellowship at Yale University. Dr. Fradkin is board-certified in Internal Medicine and in Endocrinology and Metabolism.

In her 33-year career at NIDDK, Dr. Fradkin has created or directed a diverse array of high-impact clinical and basic research programs, including multi-centered clinical trials to evaluate new approaches to prevent and treat diabetes and its complications, scientific consortia to define the genetic and environmental triggers of diabetes, and diabetes research centers. She is responsible for a major series of diabetes initiatives focused on beta cell development and function, improved glucose control through development of continuous glucose monitors and an artificial pancreas, and research on obesity, insulin action, and animal models of diabetes. 

Under Dr. Fradkin’s leadership of DEMD, major new clinical research networks have been created to conduct trials for prevention or delay of progression of type 1 diabetes, prevention of development of risk factors for type 2 diabetes in children, and comparison of treatment approaches to type 2 diabetes in children, and the landmark Diabetes Prevention Program clinical trial was successfully completed.

Dr. Fradkin serves as Chair of the Diabetes Mellitus Interagency Coordinating Committee, which is charged with facilitating collaboration on diabetes among Federal entities.  She also serves the on the Executive Committee providing leadership for the National Diabetes Education Program. 

In addition to her oversight of major biomedical research programs, she has served as an endocrinology consultant at the National Naval Medical Center in Bethesda, Maryland, since 1984.  She has also authored or co-authored over 30 articles in the peer-reviewed literature. 

The recipient of numerous NIH and Public Health Service awards, Dr. Fradkin is also the 2003 recipient of the American Medical Association’s Dr. Nathan Davis Award for outstanding public service in the advancement of public health.  She was the 2010 recipient of the Juvenile Diabetes Research Foundation Hero Award.

Dr. Fradkin is married to William Theodore, M.D., with whom she has three children.